These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 29292611)

  • 21. The relationship between circulating mitochondrial DNA and inflammatory cytokines in patients with major depression.
    Kageyama Y; Kasahara T; Kato M; Sakai S; Deguchi Y; Tani M; Kuroda K; Hattori K; Yoshida S; Goto Y; Kinoshita T; Inoue K; Kato T
    J Affect Disord; 2018 Jun; 233():15-20. PubMed ID: 28633757
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Might different cytokine trends in depressed patients receiving duloxetine indicate differential biological backgrounds.
    Fornaro M; Rocchi G; Escelsior A; Contini P; Martino M
    J Affect Disord; 2013 Mar; 145(3):300-7. PubMed ID: 22981313
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Changes in serum concentrations and in cytokine production by blood cell cultures of a patient with major depression--case report.
    Dubas-Slemp H; Kamińska T; Marmurowska-Michałowska H; Kandefer-Szerszeń M
    Ann Univ Mariae Curie Sklodowska Med; 2002; 57(2):496-504. PubMed ID: 12898886
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Altered serum levels of TNF-α, IL-6, and IL-18 in depressive disorder patients.
    Fan N; Luo Y; Ou Y; He H
    Hum Psychopharmacol; 2017 Jul; 32(4):. PubMed ID: 28582802
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum interleukin-6 is related to lower cognitive functioning in elderly patients with major depression.
    Ali NS; Hashem AHH; Hassan AM; Saleh AA; El-Baz HN
    Aging Ment Health; 2018 May; 22(5):655-661. PubMed ID: 28338340
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum Interleukin Levels and Insulin Resistance in Major Depressive Disorder.
    Al-Hakeim HK; Al-Kufi SN; Al-Dujaili AH; Maes M
    CNS Neurol Disord Drug Targets; 2018; 17(8):618-625. PubMed ID: 30033878
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association between depression, nutritional status, and inflammatory markers in peritoneal dialysis patients.
    Cilan H; Sipahioglu MH; Oguzhan N; Unal A; Turan T; Koc AN; Tokgoz B; Utas C; Oymak O
    Ren Fail; 2013; 35(1):17-22. PubMed ID: 23150953
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Altered serum interleukin-7 and interleukin-10 are associated with drug-free major depressive disorder.
    Anjum S; Qusar MMAS; Shahriar M; Islam SMA; Bhuiyan MA; Islam MR
    Ther Adv Psychopharmacol; 2020; 10():2045125320916655. PubMed ID: 32435448
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Exploration of 27 plasma immune markers: a cross-sectional comparison of 64 old psychiatric inpatients having unipolar major depression and 18 non-depressed old persons.
    Gaarden TL; Engedal K; Benth JŠ; Larsen M; Lorentzen B; Mollnes TE; Bjølseth TM; Castellheim A
    BMC Geriatr; 2018 Jun; 18(1):149. PubMed ID: 29940870
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increase in interleukin-1beta in late-life depression.
    Thomas AJ; Davis S; Morris C; Jackson E; Harrison R; O'Brien JT
    Am J Psychiatry; 2005 Jan; 162(1):175-7. PubMed ID: 15625217
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased plasma nesfatin-1 levels may be associated with corticosterone, IL-6, and CRP levels in patients with major depressive disorder.
    Xia QR; Liang J; Cao Y; Shan F; Liu Y; Xu YY
    Clin Chim Acta; 2018 May; 480():107-111. PubMed ID: 29427582
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Elevated Brain-Derived Neurotrophic Factor Correlates Negatively with Severity and Duration of Major Depressive Episodes.
    Kheirouri S; Noorazar SG; Alizadeh M; Dana-Alamdari L
    Cogn Behav Neurol; 2016 Mar; 29(1):24-31. PubMed ID: 27008247
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Can BDNF and IL-2 be indicators for the diagnosis in schizophrenic patients with depressive symptoms?
    Eker SS; Yavasci EO; Cangur S; Kirli S; Sarandol E
    Acta Neuropsychiatr; 2014 Oct; 26(5):291-7. PubMed ID: 25241757
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A pilot, open-label, 8-week study evaluating the efficacy, safety and tolerability of adjunctive minocycline for the treatment of bipolar I/II depression.
    Soczynska JK; Kennedy SH; Alsuwaidan M; Mansur RB; Li M; McAndrews MP; Brietzke E; Woldeyohannes HO; Taylor VH; McIntyre RS
    Bipolar Disord; 2017 May; 19(3):198-213. PubMed ID: 28599348
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum concentrations of CRP, IL-6, TNF-α and cortisol in major depressive disorder with melancholic or atypical features.
    Karlović D; Serretti A; Vrkić N; Martinac M; Marčinko D
    Psychiatry Res; 2012 Jun; 198(1):74-80. PubMed ID: 22386567
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Elevated macrophage migration inhibitory factor and decreased transforming growth factor-beta levels in major depression--no influence of celecoxib treatment.
    Musil R; Schwarz MJ; Riedel M; Dehning S; Cerovecki A; Spellmann I; Arolt V; Müller N
    J Affect Disord; 2011 Nov; 134(1-3):217-25. PubMed ID: 21684012
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Soluble interleukin-2 receptor levels correlated with positive symptoms during quetiapine treatment in schizophrenia-spectrum disorders.
    Igue R; Potvin S; Bah R; Stip E; Bouchard RH; Lipp O; Gendron A; Kouassi E
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Aug; 35(7):1695-8. PubMed ID: 21627977
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Exploring the relationship between vitamin D and mania: correlations between serum vitamin D levels and disease activity.
    Altunsoy N; Yüksel RN; Cingi Yirun M; Kılıçarslan A; Aydemir Ç
    Nord J Psychiatry; 2018 Apr; 72(3):221-225. PubMed ID: 29308715
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of pro-inflammatory cytokines among patients with bipolar disorder and unipolar depression and normal controls.
    Bai YM; Su TP; Li CT; Tsai SJ; Chen MH; Tu PC; Chiou WF
    Bipolar Disord; 2015 May; 17(3):269-77. PubMed ID: 25257835
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The serum zinc concentration as a potential biological marker in patients with major depressive disorder.
    Styczeń K; Sowa-Kućma M; Siwek M; Dudek D; Reczyński W; Szewczyk B; Misztak P; Topór-Mądry R; Opoka W; Nowak G
    Metab Brain Dis; 2017 Feb; 32(1):97-103. PubMed ID: 27502410
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.